IBRX - ImmunityBio, Inc.
IEX Last Trade
2.495
0.010 0.401%
Share volume: 520,443
Last Updated: Mon 13 Jan 2025 08:30:05 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$2.48
0.01
0.40%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-11 | 2023-08-08 | 2023-11-09 | 2024-03-19 | 2024-05-09 | 2024-08-12 | 2024-11-12 | |
| Total revenue | 360.000 K | 41.000 K | 82.000 K | 139.000 K | 40.000 K | 1.047 M | 6.106 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 360.000 K | 41.000 K | 82.000 K | 139.000 K | 40.000 K | 1.047 M | 6.106 M | |
| -88.61% | 100.00% | 69.51% | -71.22% | 2,517.50% | 483.19% | |||
| Operating expenses | 111.940 M | 85.186 M | 80.218 M | 84.642 M | 95.236 M | 100.380 M | 86.359 M | |
| Selling general and admin | 32.676 M | 32.018 M | 31.816 M | 33.110 M | 41.885 M | 49.251 M | 35.916 M | |
| Research and development | 79.264 M | 53.168 M | 48.402 M | 51.532 M | 53.351 M | 51.129 M | 50.443 M | |
| Total expenses | 114.277 M | 89.143 M | 81.473 M | 84.642 M | 95.236 M | 100.380 M | 86.359 M | |
| -21.99% | -8.60% | 3.89% | 12.52% | 5.40% | -13.97% | |||
| Operating income | -113.917 M | -89.102 M | -81.391 M | -84.503 M | -95.196 M | -99.333 M | -80.253 M | |
| Ebit | -113.917 M | -89.102 M | -81.391 M | -84.503 M | -95.196 M | -97.456 M | -47.303 M | |
| Pretax income | -116.583 M | -138.213 M | -95.642 M | -233.454 M | -134.130 M | -134.584 M | -85.752 M | |
| 18.55% | -30.80% | 144.09% | -42.55% | 0.34% | -36.28% | |||
| Income tax | 0.000 | 0.000 | 0.000 | -40.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.109 M | 0.000 | 0.000 | |
| -18.51% | 30.68% | -144.18% | 42.54% | 100.00% | ||||
| Net income | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.109 M | -134.584 M | -85.752 M | |
| -18.51% | 30.68% | -144.18% | 42.54% | -0.35% | 36.28% |